Cargando…
Double negative T cells, a potential biomarker for systemic lupus erythematosus
Systemic lupus erythematosus (SLE) is an autoimmune disease that is a challenge to diagnose and treat. There is an urgent need for biomarkers to help define organ involvement, and more effective therapies. A unique population of T cells, the CD3(+)CD4(−)CD8(−) (DNeg) cells, is significantly increase...
Autores principales: | Alexander, Jessy J, Jacob, Alexander, Chang, Anthony, Quigg, Richard J, Jarvis, James N |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7093895/ https://www.ncbi.nlm.nih.gov/pubmed/32257532 http://dx.doi.org/10.1093/pcmedi/pbaa001 |
Ejemplares similares
-
The Role of NETosis in Systemic Lupus Erythematosus
por: Salemme, Ryan, et al.
Publicado: (2019) -
Systemic lupus erythematosus favors the generation of IL-17 producing double negative T cells
por: Li, Hao, et al.
Publicado: (2020) -
Fecal Metabolomics and Potential Biomarkers for Systemic Lupus Erythematosus
por: Zhang, Qiong, et al.
Publicado: (2019) -
Potential Immune Biomarkers in Diagnosis and Clinical Management for Systemic Lupus Erythematosus
por: Zecevic, Lamija, et al.
Publicado: (2018) -
Salivary Cytokines as Potential Diagnostic Biomarkers for Systemic Lupus Erythematosus Disease
por: Zian, Zeineb, et al.
Publicado: (2021)